Ignite Creation Date:
2024-05-06 @ 6:46 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05788536
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2023-03-15
Brief Title:
A Study of DB-OTO an Adeno-associated Virus AAV Based Gene Therapy in ChildrenInfants With Hearing Loss Due to Otoferlin Mutations
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene OTOF |
Keywords:
| Name | View |
|---|---|
| DB-OTO | View |
| Gene Therapy | View |
| Congenital Hearing Loss | View |
| Sensorineural Hearing Loss | View |
| Auditory Neuropathy | View |
| Pediatric | View |
| Cochlear Implant | View |
| Otoferlin | View |
| Deaf | View |
| Hard of hearing | View |
| Hearing impaired | View |
| Hearing disorder | View |
| Fully implantable hearing aid | View |
| Child | View |
| Infant | View |
| CHORD | View |